Future Prospective

Today, KSP manufactures a range of pharmaceutical products of more than 120 products targeting the market demand of Gulf States , Middle East and some African territories. The company plans, in the medium run, to expand its existing pharmaceutical lines to include three major additional projects: ◦ Small Volume Parenterals (e.g. Ampoules and Vials) ◦ Sterile Drops ◦ Antibiotic Line e.g. Beta-Lactams KSP has the privilege to be licensed and approved by all the regional Health Authorities. KSP continues to seek international accreditation in quality assurance system for additional Under License and Toll manufacturing for the Middle East region. KSP have both modern plant facilities and the highest caliber professional human resources, is ready to accept further challenges in manufacturing and marketing of more products through future collaborations with reputed market leaders. Moreover, KSP is actively exploring the following business opportunities: ◦ “In-Licensing” innovative/patent products as well as Contract manufacturing for Multinational pharmaceutical companies. ◦ Marketing and distributing products of multinational pharmaceutical companies in the Middle East and Africa . ◦ Exporting finished products to leading organizations and companies in attractive markets worldwide. ◦ Technical Collaborations on new products and dosage forms